The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Growth Promotion Ethics and the Challenge to Resist Cosmetic Endocrinology
Abstract
The advancement of “human growth hormone (hGH)-for-height” – increasing height attainment in children short for reasons other than GH deficiency – arose from intuitive, deep-seated assumptions about the disability of short stature, its improvement with hGH-mediated height gain, and the safety of escalating dosages of hGH in healthy children. Evidence challenging these assumptions now strengthens criticism of hGH-for-height as cosmetic endocrinology. To counter this characterization, collective acceptance of guidelines is needed that advise nontreatment of the vast majority of short children, support strategies that minimize treatment duration and dosage, and restrain enhancement of normal adult stature. Through a clinical case analysis, ethical issues underlying these recommendations are explored. These include duties to provide informed assent and re-assent, protect children from unnecessary treatment, consider fairness to nontreated children, and allocate healthcare resources responsibly. Informed assent for hGH-for-height should ensure awareness of modest, variable height gain expectations, limited evidence for psychosocial benefit, ongoing studies for potential posttreatment adverse effects, and options for less expensive/invasive approaches, including nontreatment and counseling. Approaching growth promotion in this way fosters therapeutic restraint, resists the al lure of enhancement therapy, and minimizes contributions to society’s perception that to be taller is to be better.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cohen, P., Rogol, A. D., Deal, C. L., Saenger, P., Reiter, E. O., Ross, J. L., Chernausek, S. D., Savage, M. O., Wit, J. M., & participants, O. B. O. T. 2. I. C. W. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0509 · Cited by 737
Grimberg, A., DiVall, S. A., Polychronakos, C., Allen, D. B., Cohen, L. E., Quintos, J. B., Rossi, W. C., Feudtner, C., Murad, M. H., & on behalf of the Drug and Therapeutics Committee and Ethics Committee of the Pediatric Endocrine Society (2016) · Hormone Research in Paediatrics · doi:10.1159/000452150 · Cited by 697
Self-citationCarel, J.-C., Ecosse, E., Landier, F., Meguellati-Hakkas, D., Kaguelidou, F., Rey, G., & Coste, J. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1995 · Cited by 295
Normal Functioning and the Treatment-Enhancement Distinction
DANIELS, N. (2000) · Cambridge Quarterly of Healthcare Ethics · doi:10.1017/s0963180100903037 · Cited by 293
Allen, D. B., Backeljauw, P., Bidlingmaier, M., Biller, B. M. K., Boguszewski, M., Burman, P., Butler, G., Chihara, K., Christiansen, J., Cianfarani, S., et al. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-0873 · Cited by 237
Self-citationFinkelstein, B. S., Imperiale, T. F., Speroff, T., Marrero, U., Radcliffe, D. J., & Cuttler, L. (2002) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.156.3.230 · Cited by 220
Carrel, A. L., Myers, S. E., Whitman, B. Y., Eickhoff, J., & Allen, D. B. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1389 · Cited by 209
Self-citationTauber, M. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.352 · Cited by 208
Sävendahl, L., Maes, M., Albertsson-Wikland, K., Borgström, B., Carel, J.-C., Henrard, S., Speybroeck, N., Thomas, M., Zandwijken, G., & Hokken-Koelega, A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2882 · Cited by 179
Jukkola‐Vuorinen, A., Bloigu, R., Ebeling, T., Salmela, P. I., & Blanco, G. (2004) · Endocrine Related Cancer · doi:10.1677/erc.1.00826 · Cited by 150
Cited by
Estrogens and androgens in skeletal physiology and pathophysiology
Almeida, M., Laurent, M. R., Dubois, V., Claessens, F., O'Brien, C. A., Bouillon, R., Vanderschueren, D., & Manolagas, S. C. (2017) · Physiological Reviews · doi:10.1152/physrev.00033.2015 · Cited by 860
Digital Twins in Health Care: Ethical Implications of an Emerging Engineering Paradigm
Bruynseels, K., Santoni de Sio, F., & van den Hoven, J. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00031 · Cited by 704
Growth hormone — past, present and future
Ranke, M. B., & Wit, J. M. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.22 · Cited by 346
Cancer risks in patients treated with growth hormone in childhood: the SAGhE European cohort study
Swerdlow, A. J., Cooke, R., Beckers, D., Borgström, B., Butler, G., Carel, J.-C., Cianfarani, S., Clayton, P., Coste, J., Deodati, A., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2046 · Cited by 153
Safety and efficacy of pediatric growth hormone therapy: results from the full KIGS cohort
Maghnie, M., Ranke, M. B., Geffner, M. E., Vlachopapadopoulou, E., Ibáñez, L., Carlsson, M., Cutfield, W., Rooman, R., Gomez, R., Wajnrajch, M. P., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac517 · Cited by 120
Metadata
- Authors
- Allen, D. B.
- Venue
- Hormone Research in Paediatrics
- Publisher
- S. Karger AG
- Published
- 2017
- Volume
- 87
- Issue
- 3
- Pages
- 145-152
- ISSN
- 1663-2818 (ISSN-L)
- 1663-2826
- OpenAlex
- W2592087460
- Cited by
- 554
- References
- 33
- FWCI
- 35.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Growth Promotion Ethics and the Challenge to Resist Cosmetic Endocrinology. https://app.cochat.ai/papers/10.1159/000458526
- The paper
- Allen, D. B. (2017). Growth Promotion Ethics and the Challenge to Resist Cosmetic Endocrinology. Hormone Research in Paediatrics. https://doi.org/10.1159/000458526
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.